Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

Sensitivity and specificity of human brain glutathione concentrations measured using short-TE1H MRS at 7 T

(2016) Dinesh K. Deelchand et al.   NMR IN BIOMEDICINE

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder

(2016) Logan K. Wink et al.   Molecular Autism

N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data

(2016) Daniel A. Monti et al.   PLoS One

Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis

(2015) François Singh et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases

(2015) Cristina Carvalho et al.   Expert Review of Neurotherapeutics

Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status

(2015) Jie Zhou et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T

(2015) Melissa Terpstra et al.   MAGNETIC RESONANCE IN MEDICINE

Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy

(2015) Victor S. Van Laar et al.   NEUROBIOLOGY OF DISEASE

Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease

(2015) Maya Katz et al.   PARKINSONISM & RELATED DISORDERS

The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases

(2015) Cristina Carvalho et al.   Expert Review of Neurotherapeutics

N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI

(2014) Jignesh D. Pandya et al.   EXPERIMENTAL NEUROLOGY

Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T

(2014) Dinesh K. Deelchand et al.   MAGNETIC RESONANCE IN MEDICINE

Clinical Proton MR Spectroscopy in Central Nervous System Disorders

(2014) Gülin Öz et al.   RADIOLOGY

Pharmacokinetics of N-acetylcysteine after oral and intravenous administration to healthy cats

(2013) Jennifer L. Buur et al.   AMERICAN JOURNAL OF VETERINARY RESEARCH

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

(2013) Mary J. Holmay et al.   CLINICAL NEUROPHARMACOLOGY

Glutathione metabolism and Parkinson's disease

(2013) Michelle Smeyne et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases

(2012) William M. Johnson et al.   Nutrients

Peripheral markers in neurodegenerative patients and their first-degree relatives

(2011) Diana Olga Cristalli et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Strategies for Reducing or Preventing the Generation of Oxidative Stress

(2011) B. Poljsak   Oxidative Medicine and Cellular Longevity

N-acetylcysteine prevents loss of dopaminergic neurons in theEAAC1−/−mouse

(2010) Ari E. Berman et al.   ANNALS OF NEUROLOGY

Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem

(2010) Gülin Öz et al.   MAGNETIC RESONANCE IN MEDICINE

Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice

(2010) Joanne Clark et al.   PLoS One

Effect of N-Acetylcysteine in Attenuating Ischemic Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

(2009) A. Prabhu et al.   ANNALS OF VASCULAR SURGERY

In vivo1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T

(2009) Ivan Tkáč et al.   MAGNETIC RESONANCE IN MEDICINE

Oxidant–antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease

(2008) G. Nagesh Babu et al.   NEUROCHEMISTRY INTERNATIONAL